Cargando…
Biomarkers in Alzheimer Disease and Other Dementias: What’s Next into Pathophysiology to Support Clinical Practice and Drug Development
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611876/ https://www.ncbi.nlm.nih.gov/pubmed/36295535 http://dx.doi.org/10.3390/medicina58101374 |
| _version_ | 1784819635734970368 |
|---|---|
| author | Bougea, Anastasia |
| author_facet | Bougea, Anastasia |
| author_sort | Bougea, Anastasia |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9611876 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | MDPI |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96118762022-10-28 Biomarkers in Alzheimer Disease and Other Dementias: What’s Next into Pathophysiology to Support Clinical Practice and Drug Development Bougea, Anastasia Medicina (Kaunas) Editorial MDPI 2022-09-30 /pmc/articles/PMC9611876/ /pubmed/36295535 http://dx.doi.org/10.3390/medicina58101374 Text en © 2022 by the author. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
| spellingShingle | Editorial Bougea, Anastasia Biomarkers in Alzheimer Disease and Other Dementias: What’s Next into Pathophysiology to Support Clinical Practice and Drug Development |
| title | Biomarkers in Alzheimer Disease and Other Dementias: What’s Next into Pathophysiology to Support Clinical Practice and Drug Development |
| title_full | Biomarkers in Alzheimer Disease and Other Dementias: What’s Next into Pathophysiology to Support Clinical Practice and Drug Development |
| title_fullStr | Biomarkers in Alzheimer Disease and Other Dementias: What’s Next into Pathophysiology to Support Clinical Practice and Drug Development |
| title_full_unstemmed | Biomarkers in Alzheimer Disease and Other Dementias: What’s Next into Pathophysiology to Support Clinical Practice and Drug Development |
| title_short | Biomarkers in Alzheimer Disease and Other Dementias: What’s Next into Pathophysiology to Support Clinical Practice and Drug Development |
| title_sort | biomarkers in alzheimer disease and other dementias: what’s next into pathophysiology to support clinical practice and drug development |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611876/ https://www.ncbi.nlm.nih.gov/pubmed/36295535 http://dx.doi.org/10.3390/medicina58101374 |
| work_keys_str_mv | AT bougeaanastasia biomarkersinalzheimerdiseaseandotherdementiaswhatsnextintopathophysiologytosupportclinicalpracticeanddrugdevelopment |